Clinical Trial Update: A Relative Bioavailability and Food Effect Study of New Formulations [Phase 1]

View source ↗

Summary

Eli Lilly reports results from a Phase 1 study evaluating relative bioavailability and the effect of food on new formulations studied in rheumatoid arthritis. T…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Snippet

Sponsor: Eli Lilly and Company | Conditions: Chronic Inflammatory Disorder, Arthritis, Rheumatoid | Phase 1 | Status: COMPLETED | Results posted: 2017-04-21